» Articles » PMID: 15889954

Factors Associated with Medication Adherence in African American and White Patients with Bipolar Disorder

Overview
Specialty Psychiatry
Date 2005 May 14
PMID 15889954
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Background: African American patients may be less likely than white patients to adhere to maintenance pharmacotherapy for bipolar disorder. The purpose of this study was to examine rates of medication nonadherence, self-perceived reasons for nonadherence, and attitudes associated with non-adherence in these ethnic groups.

Method: 20 African American and 30 white subjects with DSM-IV bipolar I disorder participated in this study. At a single follow-up visit with patients at least 4 months after their first hospitalization for acute mania, we assessed demographics, symptom severity, degrees of adherence, reasons for non-adherence, and self-perceptions regarding factors previously associated with nonadherence using a visual analog scale (VAS). The cross-sectional data that are the subject of this report were obtained from July 1, 2002, through June 30, 2004.

Results: Over 50% of participants in each group were currently either fully or partially nonadherent with medications. Greater than 20% of participants in each group denied having bipolar disorder and described physical side effects from medications as contributing to nonadherence. In principal components analysis of the VAS, 2 components were identified. The first component contained patient-related factors associated with nonadherence, while the second contained a combination of illness- and medication-related factors. African American participants were more likely to endorse patient-related factors associated with nonadherence relative to white participants. Specifically, African Americans self-endorsed a fear of becoming addicted to medications and feeling that medications were symbols of mental illness.

Conclusion: Findings suggest that both African American and white patients with bipolar disorder demonstrate poor medication adherence that they attribute to illness/medication-related factors (denial of illness, physical side effects). However, patient-related factors (fear of addiction, medication as a symbol of illness) accounted for ethnic differences on self-perceived ratings of nonadherence factors. Differences in the reasons for nonadherence relative to culturally biased self-perceptions may help explain nonadherence behaviors in the African American community.

Citing Articles

Engaging Patient Advisory Boards of African American Community Members with Type 2 Diabetes in Implementing and Refining a Peer-Led Medication Adherence Intervention.

Maurer M, Shiyanbola O, Mott M, Means J Pharmacy (Basel). 2022; 10(2).

PMID: 35314618 PMC: 8938802. DOI: 10.3390/pharmacy10020037.


A Qualitative Analysis to Understand Perception about Medication-Related Problems among Older Minority Adults in a Historically Black Community.

Poon I, Skelton F, Bean L, Guinn D, Jemerson T, Mbue N Pharmacy (Basel). 2022; 10(1).

PMID: 35076623 PMC: 8788468. DOI: 10.3390/pharmacy10010014.


Mapping modifiable determinants of medication adherence in bipolar disorder (BD) to the theoretical domains framework (TDF): a systematic review.

Prajapati A, Dima A, Mosa G, Scott S, Song F, Wilson J Psychol Med. 2021; 51(7):1082-1098.

PMID: 34006337 PMC: 8188530. DOI: 10.1017/S0033291721001446.


Antipsychotic medication adherence and preventive diabetes screening in Medicaid enrollees with serious mental illness: an analysis of real-world administrative data.

Stockbridge E, Webb N, Dhakal E, Garg M, Loethen A, Miller T BMC Health Serv Res. 2021; 21(1):69.

PMID: 33461561 PMC: 7812734. DOI: 10.1186/s12913-020-06045-0.


Preliminary engagement of a patient advisory board of African American community members with type 2 diabetes in a peer-led medication adherence intervention.

Shiyanbola O, Kaiser B, Thomas G, Tarfa A Res Involv Engagem. 2021; 7(1):4.

PMID: 33407841 PMC: 7788731. DOI: 10.1186/s40900-020-00245-y.